The Stock Market Continues To Levitate
It was fun while it lasted – but the US Stock Market is back to being overvalued. My stock exposure is sitting at 20% (based […]
Month: January 2019
Options Trade – Celgene Corp (CELG)
First headline I read today: MarketWatch – Bristol-Myers to acquire Celgene in cash-and-stock deal with equity value of about $74 billion I closed out the five […]